Is the Bishop-score significant in predicting the success of labor induction in multiparous women?
To determine whether the Bishop-score upon admission effects mode of delivery, maternal or neonatal outcomes of labor induction in multiparous women.



A retrospective study including 600 multiparous women with a singleton pregnancy, 34 gestational weeks and above who underwent labor induction for maternal, fetal or combined indications. Induction was performed with one of three methods- oxytocin, a slow release vaginal prostaglandin E2 insert (10 mg dinoprostone) or a transcervical double balloon catheter. The women were divided into two groups-Bishop-score <6 and Bishop-score ⩾6. We evaluated labor course, maternal complications (postpartum hemorrhage, manual lysis, uterine revision, perineal tear grade 3-4, need for blood transfusions, relaparotomy, prolonged hospitalization) and neonatal outcomes (Apgar score, cord pH, hospitalization in the neonatal intensive care unit, prolonged hospitalization).



Both groups had a high rate of vaginal deliveries-93.7% and 94.9%, respectively. There was no difference between the two groups in terms of maternal or neonatal outcomes.



Labor induction in multiparous women is safe and successful regardless of the initial Bishop-score. In multiparous women the Bishop-score is not a good predictor for the success of labor induction, nor is it a predictor for maternal of neonatal adverse outcomes and complications.
Department of Obstetrics and Gynecology, 'Meir Medical Center', Kfar Saba, Israel.|Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.
D
D
Navve
Department of Obstetrics and Gynecology, 'Meir Medical Center', Kfar Saba, Israel.|Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.
N
N
Orenstein
Department of Obstetrics and Gynecology, 'Meir Medical Center', Kfar Saba, Israel.|Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.
R
R
Ribak
Department of Obstetrics and Gynecology, 'Meir Medical Center', Kfar Saba, Israel.|Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.
Y
Y
Daykan
Department of Obstetrics and Gynecology, 'Meir Medical Center', Kfar Saba, Israel.|Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.
G
G
Shechter-Maor
Department of Obstetrics and Gynecology, 'Meir Medical Center', Kfar Saba, Israel.|Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.
T
T
Biron-Shental
D000282:Administration, Intravaginal; D000328:Adult; D020070:Cervical Ripening / Q000502:physiology*; D015232:Dinoprostone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007557:Israel; D007751:Labor, Induced / Q000379:methods*; D007743:Labor, Obstetric / Q000502:physiology; D007744:Obstetric Labor Complications; D010120:Oxytocics / Q000008:administration & dosage; D010298:Parity; D010808:Physical Examination / Q000379:methods*; D006473:Postpartum Hemorrhage; D011237:Predictive Value of Tests; D011247:Pregnancy; D012189:Retrospective Studies
D010120:Oxytocics; D015232:Dinoprostone